Mysterious drone activity triggers massive 1,366% surge

If mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But here’s what you really need to know: An early warning signal tipped off investors to a tiny drone stock that later skyrocketed 1,366%.

👉 Click here now to see how this signal works.

Steve Miller Biography and Net Worth

COO of Catalyst Pharmaceuticals

Steven R. Miller, PhD, is responsible for Catalyst’s product development program, which includes all aspects of chemistry and manufacturing controls, quality systems, contract operations, and development planning. Dr. Miller has 25 years of experience in the pharmaceutical and healthcare industries, joining Catalyst in 2007. Most recently he has managed Catalyst’s in-licensing of CPP-115 and Catalyst’s newest drug, Firdapse®, and taken these products through various preclinical and clinical development studies. Dr. Miller previously served as Executive Director for Research and Development Operations at Watson Pharmaceuticals and as Vice President of Research and Product Development at Royce Laboratories; he has also managed medical device development groups at Baxter Diagnostics and worked as an analytical chemist for the U.S. Food and Drug Administration. Dr. Miller received his doctorate in physical organic chemistry at the University of Miami; his work has been published in numerous technical and professional journals including Journal of Analytical Chemistry, Journal of the American Chemical Society, Journal of Medicinal Chemistry, and Chemical Communications.

What is Steve Miller's net worth?: The estimated net worth of Steve Miller is at least $15.05 million as of December 10th, 2024. Dr. Miller owns 686,996 shares of Catalyst Pharmaceuticals stock worth more than $15,052,082 as of December 26th. This net worth approximation does not reflect any other investments that Dr. Miller may own. Additionally, Dr. Miller receives a salary of $884,700.00 as COO at Catalyst Pharmaceuticals. Learn More about Steve Miller's net worth.
How old is Steve Miller?: Dr. Miller is currently 62 years old. There are 6 older executives and no younger executives at Catalyst Pharmaceuticals. Learn More on Steve Miller's age.
What is Steve Miller's salary?: As the COO of Catalyst Pharmaceuticals, Inc., Dr. Miller earns $884,700.00 per year. Learn More on Steve Miller's salary.
How do I contact Steve Miller?: The corporate mailing address for Dr. Miller and other Catalyst Pharmaceuticals executives is 355 ALHAMBRA CIRCLE SUITE 1250, CORAL GABLES FL, 33134. Catalyst Pharmaceuticals can also be reached via phone at (305) 420-3200 and via email at [email protected]. Learn More on Steve Miller's contact information.
Has Steve Miller been buying or selling shares of Catalyst Pharmaceuticals?: During the past quarter, Steve Miller has sold $1,096,500.00 of Catalyst Pharmaceuticals stock. Most recently, Steve Miller sold 50,000 shares of the business's stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $21.93, for a transaction totalling $1,096,500.00. Following the completion of the sale, the insider now directly owns 686,996 shares of the company's stock, valued at $15,065,822.28. Learn More on Steve Miller's trading history.
Who are Catalyst Pharmaceuticals' active insiders?: Catalyst Pharmaceuticals' insider roster includes Philip Coelho (Director), Richard Daly (President and CEO), Jeffrey Del Carmen (EVP, Chief Commercial Officer), Donald Denkhaus (Director), Brian Elsbernd (Chief Legal and Compliance Officer), Alicia Grande (Vice President, Chief Financial Officer and Treasurer), Alicia Grande (CFO), Molly Harper (Director), Gary Ingenito (Insider), Patrick McEnany (CEO), Steve Miller (COO), Steven Miller (COO & Chief Scientific Officer ), and David Tierney (Director). Learn More on Catalyst Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Catalyst Pharmaceuticals?: In the last year, insiders at the biopharmaceutical company sold shares 12 times. They sold a total of 440,755 shares worth more than $8,352,888.44. The most recent insider tranaction occured on December, 10th when insider Steve Miller sold 50,000 shares worth more than $1,096,500.00. Insiders at Catalyst Pharmaceuticals own 11.0% of the company. Learn More about insider trades at Catalyst Pharmaceuticals.
Information on this page was last updated on 12/10/2024.

Steve Miller Insider Trading History at Catalyst Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/10/2024	Sell	50,000	$21.93	$1,096,500.00	686,996
8/20/2024	Sell	150,000	$20.35	$3,052,500.00	675,124
12/5/2023	Sell	40,000	$14.24	$569,600.00	647,457
11/23/2022	Sell	20,000	$17.34	$346,800.00	553,791
11/21/2022	Sell	80,000	$15.28	$1,222,400.00	573,791
9/13/2022	Sell	107,933	$16.90	$1,824,067.70	653,791
8/18/2022	Sell	150,000	$13.53	$2,029,500.00	761,724
8/25/2021	Sell	80,000	$5.56	$444,800.00	821,724
1/11/2016	Buy	7,933	$1.80	$14,279.40	457,687
6/4/2014	Buy	100,000	$2.17	$217,000.00

Steve Miller Buying and Selling Activity at Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Company Overview

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Today's Range

Now: $21.91

$21.45

$21.93

50 Day Range

MA: $21.80

$20.60

$23.93

2 Week Range

Now: $21.91

$13.12

$24.27

Volume

565,277 shs

Average Volume

1,161,511 shs

Market Capitalization

$2.61 billion

P/E Ratio

18.57

Dividend Yield

N/A

Beta

0.75

Mysterious drone activity triggers massive 1,366% surge

From Insiders Exposed | Ad

👉 Click here now to see how this signal works.

Steve Miller Biography and Net Worth

What is Steve Miller's net worth?

How old is Steve Miller?

What is Steve Miller's salary?

How do I contact Steve Miller?

Has Steve Miller been buying or selling shares of Catalyst Pharmaceuticals?

Who are Catalyst Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Catalyst Pharmaceuticals?